3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Glioblastoma
28
Lung Neoplasms
13
Gliosarcoma
13
Carcinoma, Non-Small-Cell Lung
13
Rectal Neoplasms
12
Brain Neoplasms
11
Squamous Cell Carcinoma of Head and Neck
10
Sarcoma
9
Prostatic Neoplasms
9
Breast Neoplasms
9
Astrocytoma
9
Uterine Cervical Neoplasms
8
Melanoma
8
Glioma
8
Esophageal Neoplasms
8
Pancreatic Neoplasms
7
Head and Neck Neoplasms
7
Neoplasm Metastasis
5
Lymphoma, Follicular
5
Oropharyngeal Neoplasms
4
Lymphoma, Mantle-Cell
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Carcinoma, Squamous Cell
4
Stomach Neoplasms
3
Ovarian Neoplasms
3
Multiple Myeloma
3
Mouth Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphoma, B-Cell
3
Interventions
pembrolizumab
3
Cyclophosphamide
3
fludarabine
2
Rosuvastatin Calcium
2
Radiotherapy
2
Paclitaxel
2
Ipilimumab
2
Interleukin-2
2
Carboplatin
2
spartalizumab
1
peposertib
1
osimertinib
1
niraparib
1
neotil
1
necitumumab
1
mirdametinib
1
apatinib
1
amivantamab
1
Valganciclovir
1
Tomography, X-Ray Computed
1
Rifampin
1
Radiation
1
Positron-Emission Tomography
1
PankoMab-GEX
1
Panitumumab
1
Nivolumab
1
Midazolam
1
Metformin
1
Magnetic Resonance Imaging
1
MEK inhibitor I
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Solid Tumor, Adult
×
Radiation
×
Clear all
NCT03728179
2024-02-20
RACIN
Centre Hospitalier Universitaire Vaudois
Phase 1
Completed
40 enrolled